Intralesional Bleomycin Versus Cryotherapy For Treatment Of Cutaneous Warts: A Randomized Controlled Trial

J Pak Med Assoc. 2023 Oct;73(10):1949-1953. doi: 10.47391/JPMA.6372.

Abstract

Objective: To evaluate the effectiveness of intralesional bleomycin in comparison to cryotherapy in the treatment of cutaneous warts.

Methods: The randomized controlled trial was conducted at the Department of Dermatology, Jinnah Postgraduate Medical Centre, Karachi, from January to July 2021, and comprised patients of either gender aged 18-60 years who had cutaneous warts for 1-48 weeks. The subjects were divided into group A treated with 0.1% intralesional bleomycin, and group B were treated with cryotherapy through non probability consecutive sampling. Follow-up examination was done at the 2, 4 and 6 weeks. Data was analysed using SPSS 23.

Results: Of the 154 patients, 96(62.3%) were male and 58(37.7%) were females. The overall mean age was 33.253±6.726 years. There were 77(50%) patients in each of the two groups. The therapy after 6 weeks was found to be effective 73(94.8%). group A patients and 57(74%) group B patients (p=0.001).

Conclusions: Intralesional bleomycin was found to be more successful than cryotherapy in the treatment of cutaneous warts.

Keywords: Cryotherapy, Cutaneous, Warts, Intralesional, Bleomycin, Randomised controlled trial..

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Bleomycin* / therapeutic use
  • Cryotherapy
  • Female
  • Hospitals
  • Humans
  • Injections, Intralesional
  • Male
  • Treatment Outcome
  • Warts* / drug therapy

Substances

  • Bleomycin